summit trial tirzepatide results Tirzepatide: A Systematic Update Effects of Tirzepatide on the

Theres no one-size-fits-all best GLP-1 drug for everyone

These data suggest that there is space for safer and tolerated best in class cAMP lowering approaches in ADPKD either targeting additional pathways regulating cAMP (PKA inhibition, PDE activation), biased V2R antagonists or combination with targets that may provide an additive or synergistic effect such as the calcium-sensing receptor (Di Mise et al., 2021

JAMAs Post Postpartum prescription of #GLP-1RAs in Denmark increased between 2018 and 2024, with #semaglutide accounting for most prescriptions since 2023

However, the efficiency of heavy metal binding by probiotics may decrease when multiple strains are combined